Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B.
| Image |  |
|---|---|
| Description | scientific article published on 16 April 2018 |
| Author/s |
author: B Wang Kosh Agarwal Ivana Carey |
| Publication date | April 16, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |